Research We Fund

Your generous support enables us to fund research every year, in locations across the globe. We fund projects across the research pipeline, from basic research through clinical trials, and our support has led to several potential treatments currently in clinical trials.

Research Initiatives

Safenowitz Postdoctoral Fellowship Program

The Milton Safenowitz Postdoctoral Fellowship for ALS Research awards are designed to encourage and facilitate young scientists to enter the field of ALS Research.  Our organization has funded 5 fellows who work with a senior mentor and receive extensive exposure to the ALS research community. More than 90% of the fellows remain in ALS research and contribute significantly to advances made in the field.

Fellows include

Nishal Shah PhD, Stanford University, California – Research on Intracortical Brain Computer Interface Technology

Lauren Gittings PhD, Barrow Institute, Phoenix, Arizona – Understanding the Pathology of C9orf72 Gene and ALS/FTD.

Sarah Ackerman PhD, University of Oregon, Eugene, OR - Contributions of astrocyte function and dysfunction to ALS

Individual Research Projects

Joe Beckman PhD, Oregon State University, Corvallis, OR - Preclinical investigation of CuATSM in mice and dogs as a precursor for ALS therapy development

Nick Olney MD, Providence ALS Center, Portland, OR – ALS Natural History Pilot Project

Yaowaree Leavell MD, Department of Neurology, Portland Veterans Affairs Hospital, Oregon - Understanding patient and care-partner experiences of primary and specialist palliative care: a qualitative needs assessment at a Veteran’s Affairs ALS Center

Jeffrey Rothstein MD, Johns Hopkins University, Baltimore Maryland - ASO mediated knockdown of CHMP7 as a novel therapeutic strategy for ALS/FTD

Daniel Fowler MD, Rapa Therapeutics, Rockville, Maryland - RAPA-501 Hybrid TREG/TH2 Cell therapy in ALS